Integrated drug profiling and CRISPR screening identify essential pathways for CAR T-cell cytotoxicity O Dufva, J Koski, P Maliniemi, A Ianevski, J Klievink, J Leitner, P Pölönen, ... Blood, The Journal of the American Society of Hematology 135 (9), 597-609, 2020 | 167 | 2020 |
A systematic review on modelling approaches for economic losses studies caused by parasites and their associated diseases in cattle M Rashid, MI Rashid, H Akbar, L Ahmad, MA Hassan, K Ashraf, K Saeed, ... Parasitology 146 (2), 129-141, 2019 | 112 | 2019 |
Comprehensive drug testing of patient-derived conditionally reprogrammed cells from castration-resistant prostate cancer K Saeed, V Rahkama, S Eldfors, D Bychkov, JP Mpindi, B Yadav, ... European urology 71 (3), 319-327, 2017 | 95 | 2017 |
Problem Management Plus (PM+): Pilot trial of a WHO transdiagnostic psychological intervention in conflict‐affected Pakistan A Rahman, N Riaz, KS Dawson, SU Hamdani, A Chiumento, M Sijbrandij, ... World Psychiatry 15 (2), 182, 2016 | 89 | 2016 |
Impact of normalization methods on high-throughput screening data with high hit rates and drug testing with dose–response data JP Mpindi, P Swapnil, B Dmitrii, S Jani, K Saeed, K Wennerberg, ... Bioinformatics 31 (23), 3815-3821, 2015 | 41 | 2015 |
Clonal heterogeneity influences drug responsiveness in renal cancer assessed by ex vivo drug testing of multiple patient‐derived cancer cells K Saeed, P Ojamies, T Pellinen, S Eldfors, R Turkki, J Lundin, P Järvinen, ... International Journal of Cancer 144 (6), 1356-1366, 2019 | 34 | 2019 |
The 5′-end heterogeneity of adenovirus virus-associated RNAI contributes to the asymmetric guide strand incorporation into the RNA-induced silencing complex N Xu, S Gkountela, K Saeed, G Akusjärvi Nucleic acids research 37 (20), 6950-6959, 2009 | 24 | 2009 |
Androgen receptor‐interacting protein HSPBAP1 facilitates growth of prostate cancer cells in androgen‐deficient conditions K Saeed, P Östling, M Björkman, T Mirtti, K Alanen, T Vesterinen, ... International journal of cancer 136 (11), 2535-2545, 2015 | 13 | 2015 |
Prevalence of injecting drug use and HIV, hepatitis B, and hepatitis C in people who inject drugs in the Eastern Mediterranean region: a systematic review and meta-analysis AM Aghaei, J Gholami, A Sangchooli, Y Rostam-Abadi, S Olamazadeh, ... The Lancet Global Health 11 (8), e1225-e1237, 2023 | 8 | 2023 |
Single-cell functional genomics reveals determinants of sensitivity and resistance to natural killer cells in blood cancers O Dufva, S Gandolfi, J Huuhtanen, O Dashevsky, H Duàn, K Saeed, ... Immunity 56 (12), 2816-2835. e13, 2023 | 7 | 2023 |
CRISPR screens identify mechanisms of natural killer cell evasion across blood cancers O Dufva, K Saeed, S Gandolfi, M Sheffer, J Klievink, P Pölönen, ... Blood 134, 3597, 2019 | 4 | 2019 |
Frequency of complications of percutaneous nephrostomy in upper obstructive uropathy K Saeed, F Qureshi, I Hussain, M Tariq Sepsis 1, 0-51, 2016 | 4 | 2016 |
Single-cell functional genomics of natural killer cell evasion in blood cancers O Dufva, S Gandolfi, J Huuhtanen, O Dashevsky, K Saeed, J Klievink, ... bioRxiv, 2022.08. 22.504722, 2022 | 3 | 2022 |
Phase 2 studies of lenalidomide, subcutaneous bortezomib, and dexamethasone as induction therapy in patients with newly diagnosed multiple myeloma P O'Gorman, JP Laubach, ME O'Dwyer, J Krawczyk, AJ Yee, O Gilligan, ... American Journal of Hematology 97 (5), 562-573, 2022 | 3 | 2022 |
Standardizing definitions for bleeding events in studies including pregnant women: A call to action K Saeed, FN Áinle Research and Practice in Thrombosis and Haemostasis 6 (7), 2022 | 2 | 2022 |
Single-Cell Functional Genomics of Natural Killer Cell Interaction with Blood Cancers O Dufva, S Gandolfi, J Huuhtanen, O Dashevsky, K Saeed, J Klievink, ... Blood 140 (Supplement 1), 8343-8344, 2022 | 1 | 2022 |
Case report: hypergranular platelets in vaccine-induced thrombotic thrombocytopenia after ChAdOx1 nCov-19 vaccination SP Comer, A Le Chevillier, PB Szklanna, S Kelliher, K Saeed, S Cullen, ... Frontiers in Cardiovascular Medicine 9, 824601, 2022 | 1 | 2022 |
Using pooled minimal genome-wide sgRNA libraries to drive oncology drug discovery S Lukasiak, A Kalinka, N Gupta, K Saeed, A Papadopoulos, U McDermott, ... Cancer Research 84 (6_Supplement), 2945-2945, 2024 | | 2024 |
Tracing back primed resistance in cancer via sister cells J Dai, S Zheng, MM Falco, J Bao, J Eriksson, S Pikkusaari, S Forstén, ... Nature Communications 15 (1), 1158, 2024 | | 2024 |
High-Throughput Screens Identify NEDD8 Inhibition As a Strategy to Augment Natural Killer Cell Cytotoxicity Against Blood Cancers J Bouhlal, P Nygren, E Jokinen, E Laajala, A Ianevski, D Dias, J Klievink, ... Blood 142, 3634, 2023 | | 2023 |